Manufacturer of Controlled Substances; Notice of Registration, 16713 [E8-6412]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 61 / Friday, March 28, 2008 / Notices
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–6389 Filed 3–27–08; 8:45 am]
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–6386 Filed 3–27–08; 8:45 am]
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
sroberts on PROD1PC70 with NOTICES
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated December 17, 2007,
and published in the Federal Register
on December 27, 2007, (72 FR 73358),
GE Healthcare, 3350 North Ridge
Avenue, Arlington Heights, Illinois
60004–1412, made application to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Cocaine (9041), a basic
class of controlled substance listed in
schedule II.
The company plans to manufacture a
radioactive product used in diagnostic
imaging in the diagnosis of Parkinson’s
Disease and for manufacture in bulk for
investigational new drug (IND)
submission and clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of GE
Healthcare to manufacture the listed
basic class of controlled substance is
consistent with the public interest at
this time. DEA has investigated GE
Healthcare to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
17:57 Mar 27, 2008
Jkt 214001
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration
BILLING CODE 4410–09–P
VerDate Aug<31>2005
BILLING CODE 4410–09–P
By Notice dated December 20, 2007,
and published in the Federal Register
on December 31, 2007, (72 FR 74331),
Chattem Chemicals, Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga,
Tennessee 37409, made application by
letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Oripavine
(9330), a basic class of controlled
substance listed in schedule II.
The company plans to manufacture
the listed controlled substance in bulk
for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chattem Chemicals, Inc. to manufacture
the listed basic class of controlled
substance is consistent with the public
interest at this time. DEA has
investigated Chattem Chemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–6412 Filed 3–27–08; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
16713
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 05–38]
Memphis Wholesale Company;
Declaratory Order Terminating
Exemption From Registration
On July 12, 2005, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Memphis Wholesale
Company (Respondent) of Memphis,
Tennessee. Show Cause Order at 1. The
Show Cause Order proposed the denial
of what it referred to as Respondent’s
‘‘application’’ for a registration as a
distributor of the list I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine (PPA), and to
revoke any exemption from registration,
on the ground that its registration ‘‘is
inconsistent with the public interest.’’
Id.
The Show Cause Order specifically
alleged that ‘‘[o]n July 29, 1997,
Memphis Wholesale Company, by its
owner, Neal Abodabba,’’ applied for a
DEA Certificate of Registration, that a
control number was assigned to its
application ‘‘permitting the firm to
temporarily operate under the
regulatory exemption [provided] at 21
CFR 1309.25, pending agency action on
the application.’’ Id. at 2. The Show
Cause Order alleged that in ‘‘April 1999,
Memphis Wholesale Company was
incorporated in the State of Tennessee
by Neal Abodabba and Shawkat
Abodabba, without notification to DEA
that the form of ownership, and thus the
registered person, had changed.’’ Id.
The Show Cause Order next alleged
that on August 10, 2000, DEA
investigators conducted an inspection of
Respondent. Id. The Order alleged that
during the inspection, Mr. Neal
Abodabba told investigators ‘‘that 7.8%
of his total sales were for ‘energy’
products, which included Max Brand
and Mini-Thins,’’ which are listed
chemical products. Id. The Order also
alleged that Mr. Abodabba also told
investigators that his customers
included approximately 200 to 300
convenience stores and gas stations,
which were located in Tennessee,
Arkansas, and northern Mississippi, and
that most of these customers purchased
listed chemical products from him. Id.
The Show Cause Order further alleged
that ‘‘in July 2000, Memphis Wholesale
had begun consolidating its deliveries in
the Nashville area by shipping to [an]
unlicensed distributor, Nashville
Wholesale, for further distribution to
retailers * * * in violation of 21 U.S.C.
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 73, Number 61 (Friday, March 28, 2008)]
[Notices]
[Page 16713]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-6412]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated December 20, 2007, and published in the Federal
Register on December 31, 2007, (72 FR 74331), Chattem Chemicals, Inc.,
3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of Oripavine (9330), a basic class
of controlled substance listed in schedule II.
The company plans to manufacture the listed controlled substance in
bulk for sale to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Chattem Chemicals, Inc. to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Chattem Chemicals, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with State and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic class of controlled substance listed.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-6412 Filed 3-27-08; 8:45 am]
BILLING CODE 4410-09-P
